RIL
JBIO

Rothschild Investment LLC’s Jade Biosciences JBIO Stock Holding History

Rothschild Investment LLC’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$933 Buy
42
+35
+500% +$730 ﹤0.01% 3073
2026
Q1 		$98 Sell
7
-2
-22% -$29 ﹤0.01% 3398
2025
Q4 		$139 Buy
9
+4
+80% +$47 ﹤0.01% 3164
2025
Q3 		$43 Sell
5
-25
-83% -$204 ﹤0.01% 3096
2025
Q2 		$300 Buy
30
+23
+329% +$783 ﹤0.01% 2860
2025
Q1 		$577 Hold
7
– – ﹤0.01% 2575
2024
Q4 		$623 Buy
7
+5
+250% +$431 ﹤0.01% 2449
2024
Q3 		$146 Buy
+2
New +$129 ﹤0.01% 2766

Other funds holding JBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Rothschild Investment LLC's JBIO Position: Q2 2026 in Review

Rothschild Investment LLC increased its Jade Biosciences (JBIO) stake by 500% in Q2 2026, buying an estimated $730 and bringing the position to 42 shares worth $933. The position accounts for ﹤0.01% of the portfolio, ranked #3073.

Rothschild Investment LLC first reported a position in JBIO in Q3 2024 and has held it in 8 quarters since. 40 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Rothschild Investment LLC held 42 shares of Jade Biosciences worth $933 as of Q2 2026.
  • Rothschild Investment LLC bought 35 Jade Biosciences shares in Q2 2026, an estimated $730.
  • Jade Biosciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3073 holding.
  • Rothschild Investment LLC first reported a position in Jade Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 40 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.